Prophylaxis in Adults with Hemophilia

[1]  A. Tagliaferri.  Awaiting evidence‐based recommendations on prophylaxis in adult patients , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  R. Liesner,et al.  A United Kingdom Haemophilia Centre Doctors’ Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A , 2010, British journal of haematology.

[3]  M. Morfini,et al.  Efficacy and safety of secondary prophylactic vs. on‐demand sucrose‐formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13‐month crossover study , 2010, Journal of thrombosis and haemostasis : JTH.

[4]  L. Valentino.  Controversies regarding the prophylactic management of adults with severe haemophilia A , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[5]  L. Valentino,et al.  Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  P. Petrini,et al.  Haemophilia care in adolescents – compliance and lifestyle issues , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[7]  R. Madhok,et al.  Challenges and controversies in haemophilia care in adulthood , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  P. Mannucci,et al.  Effects of secondary prophylaxis started in adolescent and adult haemophiliacs , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  C. Hermans,et al.  Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[10]  Alan R. Cohen,et al.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.

[11]  C. Hay.  Prophylaxis in adults with haemophilia , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[12]  S. Darby,et al.  Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. , 2007, Blood.

[13]  R. Ljung,et al.  Changing pattern of care of boys with haemophilia in western European centres , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

[14]  J. Astermark,et al.  Consensus perspectives on prophylactic therapy for haemophilia: summary statement , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[15]  E. Berntorp.  Prophylactic therapy for haemophilia: early experience , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  D. Grobbee,et al.  Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  H. Pettersson,et al.  Haemophilia prophylaxis in young patients–a long‐term follow‐up , 1997, Journal of internal medicine.

[18]  P. Mannucci,et al.  Modern treatment of haemophilia. , 1995, Bulletin of the World Health Organization.

[19]  H. Pettersson,et al.  Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.

[20]  M. Blombäck,et al.  Prophylaxis with factor concentrates in preventing hemophilic arthropathy. , 1991, The American journal of pediatric hematology/oncology.